Position in PFE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,242,356
+$399,209 QoQ
Shares Held
79,856
+7.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Arax Advisory Partners holds $77,931,464 across 17 Drug Manufacturers - General names. PFE ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
303,856 | $36,550,838 | |
| 2 | ABBV |
AbbVie Inc.
|
48,857 | $10,625,908 | |
| 3 | JNJ |
Johnson & Johnson
|
41,381 | $10,115,171 | |
| 4 | LLY |
ELI LILLY & Co
|
6,998 | $6,436,550 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
73,108 | $4,434,000 | |
| 6 | PFE |
Pfizer Inc
This page
|
79,856 | $2,242,356 | |
| 7 | AMGN |
Amgen Inc
|
5,229 | $1,839,823 | |
| 8 | AZN |
Astrazeneca PLC
|
6,722 | $1,325,712 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,242,356 | 79,856 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,843,147 | 74,022 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,000,232 | 156,995 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $753,767 | 31,096 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $538,144 | 21,237 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,034,059 | 38,977 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $282,106 | 9,748 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $258,506 | 9,239 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $234,542 | 8,452 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $239,647 | 8,324 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $328,481 | 9,903 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $396,180 | 10,801 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $604,288 | 14,811 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $767,523 | 14,979 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $650,186 | 14,858 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $713,991 | 13,618 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $693,718 | 13,400 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $778,633 | 13,186 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $316,166 | 7,351 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $268,089 | 6,846 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $383,044 | 10,406 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $360,349 | 10,349 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $225,487 | 7,268 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $324,851 | 10,490 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||